Dry eye

Only two drugs are currently approved to treat dry eye disease (DED). Even though it is well known that inflammation plays an important role in DED, the causes of inflammation remain largely unknown and prevent development of new treatments.

Researchers have found that neutrophils are present on the ocular surface of patients with severe tear-deficient DED subtypes that have a web-like nuclear chromatin complex (neutrophil extracellular traps [NETs]). NETs accumulate on the ocular surface in patients with DED because of…

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. May 28, 2019

New Data Challenges Current Beliefs Surrounding Dry Eye, LASIK

Conventional wisdom concerning dry eye and LASIK does not always hold true, claims Julie Schallhorn, MD, MS, assistant professor of Ophthalmology, University of California San Francisco, who presented findings from a large population-based study of patients undergoing…

Journal Scan

  1. Aug 27, 2019

Pilot Clinical Trial Shows DNase Eye Drops May Improve Dry Eye Symptoms

Only two drugs are currently approved to treat dry eye disease (DED). Even though it is well known that inflammation plays an important role in DED, the causes of inflammation remain largely unknown and prevent development of new treatments.